Molecular characterisation of tumours of the lacrimal apparatus
Histopathology · 2023
DOI: 10.1111/his.15040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2023. Verfasst von Roseline Vibert und 14 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacogenomics Unit, Department of Genetics, Institut Curie, PSL Research University, Paris, France. Hauptthemen laut MEDLINE: Lacrimal Apparatus, Carcinoma, Adenoid Cystic, Adenoma, Pleomorphic, Salivary Gland Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: France Génomique Consortium, SiRIC-Curie Program.
Abstract (Originalsprache)
Aims
Malignant tumours of the lacrimal apparatus are rare and frequently show a poor prognosis, with no clear therapeutic standards. Characterisation of the genetic landscape of these rare tumours is sparse, and therefore therapeutics generally follow those of their common salivary gland counterparts. To further clarify the pathophysiology and discover potential therapeutic targets, we investigated the genetic landscape of eight tumours of the lacrimal apparatus. Methods and results DNA and RNA sequencing were performed to identify genetic mutations and gene fusions. Immunohistochemistry, fluorescence in‐situ hybridisation and reverse transcription–polymerase chain reaction followed by Sanger sequencing were performed to confirm the identified molecular alterations. Genetic alterations were detected in six tumours. Among five adenoid cystic carcinomas (ACC), four had confirmed alterations of MYB or MYBL1 genes, including a MYB :: NFIB fusion, a MYBL1 :: NFIB fusion, a MYB amplification and a novel NFIB :: THSD7B fusion. Mutations in genes encoding epigenetic modifiers, as well as NOTCH1 , FGFR2 and ATM mutations, were also identified in ACCs. A carcinoma ex pleomorphic adenoma showed TP53 and CIC mutations and an amplification of ERBB2 . A transitional cell carcinoma was associated with HPV16 infection. No genetic alteration was found for one adenocarcinoma, not otherwise specified.
Conclusions
Our study highlights the variety of molecular alterations associated with lacrimal system tumours and emphasises the importance of molecular testing in these tumours, which can reveal potentially targetable mutations. Our results also reinforce the hypothesis of a common physiopathology of all ACCs, regardless of their primary location.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacogenomics Unit, Department of Genetics, Institut Curie, PSL Research University, Paris, France.
- Department of Pathology, Institut Curie, PSL Research University, Paris, France.
- Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France.
- Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.
- Institut Curie Genomics of Excellence (ICGex) NGS Platform, Institut Curie, Paris, France.
- Thorax Institute Curie Montsouris, Institut Curie, Paris, France.
ORCID-Profile: Roseline Vibert, Anne Vincent-Salomon
Förderung
- France Génomique Consortium
- SiRIC-Curie Program
Zitieren
APA
Vibert, R., Cyrta, J., Girard, E., Vacher, S., Dupain, C., Antonio, S., Wong, J., Baulande, S., De Sousa, J. M. F., Vincent-Salomon, A., Masliah-Planchon, J., Girard, N., Le Tourneau, C., Kamal, M., & Bièche, I. (2023). Molecular characterisation of tumours of the lacrimal apparatus. Histopathology. https://doi.org/10.1111/his.15040
Vancouver
Vibert R, Cyrta J, Girard E, Vacher S, Dupain C, Antonio S, et al. Molecular characterisation of tumours of the lacrimal apparatus. Histopathology. 2023. doi:10.1111/his.15040
BibTeX
@article{Vibert2023,
author = {Vibert, Roseline and Cyrta, Joanna and Girard, Elodie and Vacher, Sophie and Dupain, Célia and Antonio, Samantha and Wong, Jennifer and Baulande, Sylvain and De Sousa, Juliana Monteiro Ferras and Vincent-Salomon, Anne and Masliah-Planchon, Julien and Girard, Nicolas and Le Tourneau, Christophe and Kamal, Maud and Bièche, Ivan},
title = {Molecular characterisation of tumours of the lacrimal apparatus},
journal = {Histopathology},
year = {2023},
doi = {10.1111/his.15040}
}
EUVIMED